Showing results (251-260 of 601) with videos related to

Sort By:
Pageof 61
Brain : a Journal of Neurology|April 1, 2005
Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosisSabine Cepok, Berit Rosche, Verena Grummel, et al.
Drug Safety|January 5, 2019
Managing Risks with Immune Therapies in Multiple SclerosisMoritz Förster, Patrick Küry, Orhan Aktas, et al.
Frontiers in Neurology|August 15, 2022
Case report: First case of neuromelioidosis in Europe: CNS infection caused by <i>Burkholderia pseudomallei</i>Nikolaos G Dimitriou, Greta Flüh, Sabine Zange, et al.
Trends in Molecular Medicine|March 20, 2018
Human Endogenous Retroviruses in Neurological DiseasesPatrick Küry, Avindra Nath, Alain Créange, et al.
Archives of Neurology|April 13, 2011
Influence of the HLA-DRB1 genotype on antibody development to interferon beta in multiple sclerosisDorothea Buck, Sabine Cepok, Steve Hoffmann, et al.
Glia|June 23, 2009
Expression of antigen processing and presenting molecules by Schwann cells in inflammatory neuropathiesGerd Meyer Zu Horste, Holger Heidenreich, Helmar C Lehmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2013
An assay to quantify species-specific anti-JC virus antibody levels in MS patientsClemens Warnke, Michael Pawlita, Thomas Dehmel, et al.
Drugs in R&D|August 28, 2023
The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing-Remitting and Secondary Progressive Multiple SclerosisMartin Vališ, Anat Achiron, Hans Peter Hartung, et al.
Annals of Neurology|October 23, 2009
Cerebrospinal fluid of brain trauma patients inhibits in vitro neuronal network function via NMDA receptorsFrauke Otto, Sebastian Illes, Jessica Opatz, et al.
Molecular Neurodegeneration|August 3, 2016
Activation of Wnt signaling promotes hippocampal neurogenesis in experimental autoimmune encephalomyelitisReiner Schneider, Barbara Koop, Friederike Schröter, et al.
Pageof 61